Cargando…
Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?
It is now 40 years since bisphosphonates (BPs) were first used in the clinic. So, it is timely to provide a brief review of what we have learned about these agents in bone disease. BPs are bone-specific and have been classified into two major groups on the basis of their distinct molecular modes of...
Autores principales: | Xu, Xiao-Long, Gou, Wen-Long, Wang, Ai-Yuan, Wang, Yu, Guo, Quan-Yi, Lu, Qiang, Lu, Shi-Bi, Peng, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874605/ https://www.ncbi.nlm.nih.gov/pubmed/24330728 http://dx.doi.org/10.1186/1479-5876-11-303 |
Ejemplares similares
-
Management of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?
por: Läckgren, Göran, et al.
Publicado: (2021) -
Ultrasound Imaging in Psoriatic Arthritis: What Have We Learnt in the Last Five Years?
por: Dubash, Sayam R., et al.
Publicado: (2020) -
Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
por: Cárdenas-Camarena, Lázaro, et al.
Publicado: (2023) -
What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014) -
What Have We Learnt about BCG Vaccination in the Last 20 Years?
por: Dockrell, Hazel M., et al.
Publicado: (2017)